In this study, we hypothesized that CCN5 gene transfer may have a therapeutic effect in the context of cardiac function and fibrosis because we previously reported that CCN5 gene therapy reversed pre-established cardiac fibrosis and prevented further deterioration of cardiac function in a TAC-induced heart failure model (11). This evidence concerns the gene CCN5 and heart failure.